QR Code

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies

We summarize here in vitro evidences of efficacy for convalescent plasma, currently approved vaccines and monoclonal antibodies against SARS-CoV-2 variants of concern (VOC: B.1.1.7, B.1.351, P.1, and B.1.617.2), variants of interest (VOI: B.1.427/B.1.429, P.2, B.1.525, P.3, B.1.526, and B.1.671.1),...

Description complète

Enregistré dans:
Auteurs principaux: Daniele Focosi, Marco Tuccori, Andreina Baj, Fabrizio Maggi
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2021-06-01
Collection:Viruses
Sujets:
COVID-19
SARS-CoV-2
convalescent plasma
neutralizing antibody
immune escape
mutations
Accès en ligne:https://www.mdpi.com/1999-4915/13/7/1211
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires